Working… Menu
Trial record 1 of 1 for:    CNS Pharmaceuticals, Inc. [Lead]
Previous Study | Return to List | Next Study

A Study of Berubicin in Adult Subjects With Recurrent Glioblastoma Multiforme

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04762069
Recruitment Status : Recruiting
First Posted : February 21, 2021
Last Update Posted : November 23, 2021
Worldwide Clinical Trials
Information provided by (Responsible Party):
CNS Pharmaceuticals, Inc.

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : October 2024
Estimated Study Completion Date : February 2025